Blockage of tropomyosin receptor kinase a (TrkA) enhances chemo-sensitivity in breast cancer cells and inhibits metastasis in vivo

International Journal of Clinical and Experimental Medicine

Volumn 8, Issue 1, 2015, Pages 634-641

  Zhang, Ju ^a   Wang, Lun Shan ^a   Ye, Shu Lai ^a   Luo, Peng ^a   Wang, Bao Long ^a  

^a ANHUI MEDICAL UNIVERSITY   (China)

Author keywords

Breast cancer; Metastasis; SiRNA; TrkA

Indexed keywords

CASPASE 3; MESSENGER RNA; PACLITAXEL; PROTEIN TYROSINE KINASE; SMALL INTERFERING RNA; TRANSCRIPTION FACTOR RELA; TROPOMYOSIN RECEPTOR KINASE A; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; BREAST CANCER; BREAST CANCER CELL LINE; CANCER INHIBITION; CELL CYCLE ARREST; CELL PROLIFERATION; CHEMOSENSITIVITY; CONTROLLED STUDY; DRUG EFFICACY; DRUG POTENTIATION; ENZYME INHIBITION; FLOW CYTOMETRY; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; LUNG METASTASIS; MOUSE; NONHUMAN; PLASMID; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; RECEPTOR DOWN REGULATION; SIGNAL TRANSDUCTION; TUMOR XENOGRAFT; WESTERN BLOTTING;

MUS;

EID: 84923058394     PISSN: None     EISSN: 19405901     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. Holleczek B and Brenner H. Trends of population-based breast cancer survival in Germany and the US: decreasing discrepancies, but persistent survival gap of elderly patients in Germany. BMC Cancer 2012; 12: 317.
2. Hurvitz SA, Dalenc F, Campone M, O’Regan RM, Tjan-Heijnen VC, Gligorov J, Llombart A, Jhangiani H, Mirshahidi HR, Tan-Chiu E, Miao S, El-Hashimy M, Lincy J, Taran T, Soria JC, Sahmoud T and Andre F. A phase 2 study of everolimus combined with trastuzumab and paclitaxel in patients with HER2-overexpressing advanced breast cancer that progressed during prior trastuzumab and taxane therapy. Breast Cancer Res Treat 2013; 141: 437-446.
3. Chao MV. Neurotrophins and their receptors: a convergence point for many signalling pathways. Nat Rev Neurosci 2003; 4: 299-309.
4. Dang C, Zhang Y, Ma Q and Shimahara Y. Expression of nerve growth factor receptors is correlated with progression and prognosis of human pancreatic cancer. J Gastroenterol Hepatol 2006; 21: 850-858.
5. Sanchez C, Clementi M, Benitez D, Contreras H, Huidobro C and Castellon E. Effect of GnRH analogs on the expression of TrkA and p 75 neurotrophin receptors in primary cell cultures from human prostate adenocarcinoma. Prostate 2005; 65: 195-202.
6. Dolle L, Adriaenssens E, El Yazidi-Belkoura I, Le Bourhis X, Nurcombe V and Hondermarck H. Nerve growth factor receptors and signaling in breast cancer. Curr Cancer Drug Targets 2004; 4: 463-470.
7. Davidson B, Reich R, Lazarovici P, Ann Florenes V, Nielsen S and Nesland JM. Altered expression and activation of the nerve growth factor receptors TrkA and p75 provide the first evidence of tumor progression to effusion in breast carcinoma. Breast Cancer Res Treat 2004; 83: 119-128.
8. Hong S, Kim J, Seo JH, Jung KH and Hong SS. Design, synthesis, and evaluation of 3,5-disubstituted 7-azaindoles as Trk inhibitors with anticancer and antiangiogenic activities. J Med Chem 2012; 55: 5337-5349.
9. Liu D, Zhang Y, Dang C, Ma Q, Lee W and Chen W. siRNA directed against TrkA sensitizes human pancreatic cancer cells to apoptosis induced by gemcitabine through an inactivation of PI3K/Akt-dependent pathway. Oncol Rep 2007; 18: 673-677.
10. Miknyoczki SJ, Chang H, Klein-Szanto A, Dionne CA and Ruggeri BA. The Trk tyrosine kinase inhibitor CEP-701 (KT-5555) exhibits significant antitumor efficacy in preclinical xenograft models of human pancreatic ductal adenocarcinoma. Clin Cancer Res 1999; 5: 2205-2212.
11. Lagadec C, Meignan S, Adriaenssens E, Foveau B, Vanhecke E, Romon R, Toillon RA, Oxombre B, Hondermarck H and Le Bourhis X. TrkA overexpression enhances growth and metastasis of breast cancer cells. Oncogene 2009; 28: 1960-1970.
12. Froger A and Hall JE. Transformation of plasmid DNA into E. coli using the heat shock method. J Vis Exp 2007; 253.
13. Patel D, Nan Y, Shen M, Ritthipichai K, Zhu X and Zhang YJ. Porcine reproductive and respiratory syndrome virus inhibits type I interferon signaling by blocking STAT1/STAT2 nuclear translocation. J Virol 2010; 84: 11045-11055.
14. Tacconelli A, Farina AR, Cappabianca L, Gulino A and Mackay AR. TrkAIII. A novel hypoxia-regulated alternative TrkA splice variant of potential physiological and pathological importance. Cell Cycle 2005; 4: 8-9.
15. Com E, Lagadec C, Page A, El Yazidi-Belkoura I, Slomianny C, Spencer A, Hammache D, Rudkin BB and Hondermarck H. Nerve growth factor receptor TrkA signaling in breast cancer cells involves Ku70 to prevent apoptosis. Mol Cell Proteomics 2007; 6: 1842-1854.
16. Naderi A and Hughes-Davies L. Nerve growth factor/nuclear factor-kappaB pathway as a therapeutic target in breast cancer. J Cancer Res Clin Oncol 2009; 135: 211-216.
17. Shi Y. Mammalian RNAi for the masses. Trends Genet 2003; 19: 9-12.